Gainor highlighted that anyone can develop lung cancer, including people who have never smoked, and addressed the stigma that ...

For Ashliann Mazeika, a diagnosis at 24 led to a decade-long treatment journey affirmed by the Breast Cancer Index test. For ...

For me, five years after being declared NED (No Evidence of Disease - the medical term for remission) following treatment for ...

Updated NCCN Clinical Practice Guidelines in Oncology now recognize that MammaPrint and BluePrint testing can help identify a ...

Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

Differentiating palliative care from hospice is crucial; palliative care focuses on holistic treatment, while hospice ...

The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...

The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...

When San Francisco-based surgeon Dr. Anne Peled decided to undergo a sensation-preserving mastectomy following her second ...

Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis on patient-centered decision-making.

Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with ...